Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$8.57 - $12.69 $25.3 Million - $37.5 Million
-2,956,700 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$8.12 - $13.12 $2.94 Million - $4.75 Million
361,700 Added 13.94%
2,956,700 $36.5 Million
Q1 2020

May 26, 2020

BUY
$6.69 - $13.45 $17.4 Million - $34.9 Million
2,595,000 New
2,595,000 $23.3 Million
Q2 2019

Aug 15, 2019

SELL
$8.12 - $15.72 $6.27 Million - $12.1 Million
-771,975 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$15.58 - $20.01 $10.4 Million - $13.4 Million
-667,300 Reduced 46.36%
771,975 $12.1 Million
Q4 2018

Feb 12, 2019

BUY
$14.59 - $23.84 $21 Million - $34.3 Million
1,439,275 New
1,439,275 $22.2 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Noked Capital LTD Portfolio

Follow Noked Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Noked Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Noked Capital LTD with notifications on news.